Additionally, the overexpression of METTL3 and its oncogenic role has been revealed in various cancers such as gastric cancer [53], hepatocellular carcinoma [54], hepatoblastoma [55], colorectal cancer [56], bladder cancer [57, 58] and lung cancer [59, 60]. This evidence concerns the gene METTL3 and gastric cancer.